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LONG TERM FOLLOWUP OF FRESH OSTEOCHONDRAL
ALLOGRAFTING OF THE FEMORAL CONDYLE
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for Orthopaedic Res. & Ed. at Scripps Clinic, La Jolla, CA, USA; 2 Tel Aviv
Med. Ctr., Div. of Orthopaedic Surgery, Tel Aviv, Israel; 3Univ. of
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Background and purpuse: Articular cartilage injuries of the distal femur
are a challenging clinical entity. Fresh osteochondral allografting (OCA) is
an increasingly popular option for articular cartilage restoration. Many
short-term follow up studies demonstrate promising clinical results, but
there are few long-term follow up studies that provide information about
graft survivorship and durability. The purpose of this study was to assess
long-term clinical outcome, determine frequency and types of reopera-
tions, determine survivorship, and to evaluate predictors of OCA failure in
patientsundergoing freshOCAtransplantationdue tovariouspathologies.
Methods: Since 1983, our IRB-approved OCA outcomes program has
collected data on 614 OCA transplantation procedures of the knee
performed in 536 patients. Of those, we evaluated 122 patients (129
knees) who underwent OCA transplantation of the femoral condyle,
were at least ten years out from the index surgery and had a minimum
two-year followup. Mean age was 31.7 years (range, 15- 68 years); 85%
were younger than 45 years. 53% were male 47% were female. Diag-
noses included osteochondritis dissecans (45%), traumatic cartilage
injury (22.5%), degenerative chondral lesion (15.5%), avascular necrosis
(14.7%), and osteochondral fracture (2.3%). Average total graft area was
8.1 cm2 (range, 0.7-28.5 cm2). Clinical evaluation included the modiﬁed
D'Aubigne and Postel (18-point) scale, International Knee Documenta-
tion Committee (IKDC) pain and function scores, Knee Society (KS)
function scores and measures of subjective satisfaction. Reoperations
and failures were recorded. Graft failure was deﬁned as revision OCA, or
conversion to arthroplasty.
Results: Mean followup was 14.2 years (range, 2-27.5 years). Mean 18-
point score improved from 12.1 to 16.0, mean IKDC pain score improved
from 7.0 to 3.8, mean IKDC function score from 3.4 to 7.2, andmean KS-F
score from 65.6 to 82.5 (all, p<0.001), Subjectively, 97% of patients were
satisﬁed with their outcome. Sixty-one knees (47%) were re-operated.
Thirty knees (23%) had reoperations not necessarily related to the graft.
Thirty-one knees (24%) failed at a mean of 7.2  5.2 years (range, 1-19.7
years). Fifteen underwent revision OCA (48%) and 16 arthroplasty
conversions (52%). Kaplan Meier survivorship analysis showed survival
rates was 82% at ten, 74% at 15, and 66% at 20 years (ﬁgure 1). Logistic
regression analysis demonstrated that age 30 years at time of surgery
and having two or more previous surgeries in the operated knee were
associated with allograft failure.
Conclusion: Ostechondral allografting appears useful in treating wide
spectrum articular cartilage pathology. OCA resulted in durable improve-
ment in pain and function, with graft survivorship of 82% at 10 years.62
IN SITU CROSS-LINKABLE HYALURONAN FOR CARTILAGE REPAIR
C. Aulin 1, P. Hedenqvist 2, M. Jensen-Waern 3, J. Hilborn 4,
T. Engstrand 5. 1Karolinska Inst., Stockholm, Sweden; 2 Swedish Univ. of
agricultural Sci.s, Uppsala, Sweden; 3 Swedish Univ. of agricultural Sci.s,
Uppsala, Sweden; 4Uppsala Univ., Uppsala, Sweden; 5Karolinska Univ.
Hosp., Stockholm, Sweden
Purpose: We have investigated the feasibility of an in situ cross-link-
able hyaluronan hydrogel system for cartilage repair in vitro and in vivo.
The hydrogel system is a two-component system based on aldehyde-
modiﬁed hyaluronic acid and hydrazide-modiﬁed polyvinyl alcohol,
which are rapidly cross-linked in situ upon mixing of the two polymer
components. The chemical modiﬁcation of this particular hyaluronan
formulation is low; approximately 5% of the carboxyl groups of the
backbone are modiﬁed.
Methods: Chondrocytes or mesenchymal stem cells were encapsulated
in the gel and cultured in chondrogenicmedium for 28 days. The in vitro
tissue formationwas analyzed by histology, immunohistochemistry and
dimethylmethylene blue assay for glucoseaminoglycan content. The in
vivo performance of the gel was studied as regeneration of local defects
in a rabbit model. A defect of 4 mm diameter was created on the medial
femoral condyle in the knee joints of 6 month old New Zealand White
rabbits. After assuring access to stem cells from subchondral bone by
bleeding, the patellawas relocated in position and the knee capsule was
tightly sutured before a volume of 0.4 ml of the hydrogel system was
injected into the knee joint. The same defect were created on the
contralateral knees, but was left untreated to serve as controls. The
animals were sacriﬁced after 3 or 6 months and the joints processed for
histopathological examination.
Results: We demonstrated that chondrocytes and mesenchymal cells
cultured in the hydrogel form cartilage-like tissue, rich in glucosami-
noglycans, collagen type II and aggrecan. In the rabbit animal model the
injection of the hydrogel improved the healing of full-thickness carti-
lage defect in the knee as compared to non-treated controls. The in vivo
study showed that the regenerated cartilage defects stained more
intense for type II collagen upon treatment with the hydrogel. Here and
in previous studies of bone regeneration using these materials, no
inﬂammatory response or capsule formation has been observed.
Conclusions: The results are very promising, and the hydrogel system
could be used both for cell based and cell free regeneration therapies.
Future studies are aimed to explore and develop a newway to contribute
to the repair of impaired bone and cartilage tissue in osteoarthritis. This
is based on the known facts that inﬂammatory stimuli as well as
mechanical load contributes to cartilage and bone damage in OA, and
that repair demands that the tissue should be supported with 1)
adequate biomechanical stimuli 2) suppress destructive inﬂammation
and 3) stimulate regeneration with anabolic factors. The hyaluronan
hydrogel systemwould provide the biomechanical support and ability to
deliver anti-inﬂammatory and anabolic factors to promote regeneration.
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THE CHONDROPROTECTIVE EFFECT OF FGF9 IN AN EXPERIMENT
MODEL OF OSTEOARTHRITIS
S.X. Wang 1, A.M. Bendele 2, E.M. Moore 3. 1 Synarc, Newark, CA, USA;
2Bolder BioPATH, Boulder, CO, USA; 3Omeros, Seattle, WA, USA
Purpose: To study the chondroprotective effect of local delivery of FGF9
in a rat meniscal tear model of osteoarthritis.
Methods: 34 skeletally mature male Lewis rats underwent surgery to
create full-thickness transection of the medial collateral ligament and
the medial meniscus of the right knee. Twoweeks after surgery animals
were randomized into two treatment groups: 18 animals received bi-
weekly intra-articular injections of 4 mg FGF9 in 50 ml saline for total of 3
weeks. A parallel treatment group included 16 animals that received
only 50 ml saline. Three days after the last injection, animals were
euthanized and 40 joints (6 normal, 16 surgery, 18 surgery + FGF9) were
processed and sections stained with toluidine blue. Quantitative and
semi-quantitative histopathological evaluationwas performed to assess
the osteoarthritic changes of the operated joints and the effect of FGF9
treatment in the medial tibial plateau region. The parameters that were
evaluated include: cartilage degeneration score, tibial cartilage degen-
eration width, cartilage thickness and depth of lesions, semi-quantita-
tive collagen damage assessment, percent proteoglycan loss, and
cartilage viability.
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used to assess cartilage damage. FGF9 treatment reduced the cartilage
degeneration score for the outer region of the medial tibial plateau by
33% (p ¼ 0.004), the width of signiﬁcant cartilage damage by 38% (p ¼
0.018), and the depth of cartilage lesions by 20-44% (p ¼ 0.003). Image
analysis showed that FGF9 increased the total cartilage area by 24% (p<
0.001) and the viable cartilage area by 35% (p < 0.001). Proteoglycan
loss was reduced by 43% (p ¼ 0.003) and the area that showed minimal
damage to the collagenwas increased two-fold. FGF9 had no signiﬁcant
effect on the subchondral bone but increased the size of the chon-
drophytes/osteophytes by 29% (p ¼ 0.001).
Conclusions: The local delivery of FGF9 in an OA model provided
signiﬁcant beneﬁcial effect on the damaged cartilage. Our data indicates
that FGF9 may be a disease-modifying drug candidate for the treatment
of osteoarthritis.
Conclusions: The local delivery of FGF9 in an OA model provided
signiﬁcant beneﬁcial effect on the damaged cartilage. Our data indicates
that FGF9 may be a disease-modifying drug candidate for the treatment
of osteoarthritis.ĂĂ64
INCREASED METHYLATION STATUS OF SOX9 GENE PROMOTER IN
HUMAN OSTEOARTHRITIC CARTILAGE
K. Kim, J. Lee, J. Lee, G.-I. Im. Dongguk Univ. Ilsan Hosp., Goyang, Republic
of Korea
Purpose: DNA methylation and modiﬁcation of nucleosome histone
tails are essential contributors to the mechanisms of epigenetic control
of gene expression. In this study, we tested the hypothesis that meth-
ylation status of SOX-9 gene promoter region is different in osteoar-
thritic (OA) cartilage from those of normal cartilage.
Methods: Femoral heads were obtained from 10 patients who had
femoral neck fractures without OA, and also from 10 OA patients
undergoing total hip arthroplasty. For methylation speciﬁc polymerase
chain reaction (MS-PCR), CpG rich regions within upstream sequences 5
kb from the transcription start site were analyzed. Putative CpG-rich
islands and respective primers for MS-PCR were searched from the CpGIsland Searcher and the MethPrimer program, respectively. In bisulﬁte
sequencing, primers were designed based on MethPrimer program and
sequences were analyzed using 2BLAST.
Results: Methylation of SOX-9 promoter region increased in OA carti-
lage compared to normal cartilage. FromMS-PCR, methylation status of
SOX-9 for R3 (from -3653 to -3496, p¼0.0186) and R4-1 (from -3111 to
-2983, p¼0.0014) signiﬁcantly increased in OA cartilage compared
to normal cartilage. When we analyzed regions (BSQ1-5) from -4548 to
-2846 in the promoter of SOX-9 by bisulﬁte sequencing, methylated
CpG sites signiﬁcantly increased in all the examined regions: total
methylated CpG sites increased about eight-fold in OA cartilage
(14.04%) than in normal cartilage (1.66%).
Conclusions: Our study suggests that the increased methylation status
in the SOX-9 promoter region may have a close relation to the
progression of OA.
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MICROARRAY STUDIES OF SYNOVIAL SPECIMEN OF EARLY HUMAN
(CHECK) AND EXPERIMENTAL OA IDENTIFY PATHWAYS AND
PROCESSES ASSOCIATED WITH CARTILAGE DAMAGE
A.B. Blom 1, P.L. van Lent 1, M. van den Bosch 1, H. Cats 2, P.M. van der
Kraan 1, W.B. van den Berg 1. 1Radboud Univ. Med. Ctr. Nijmegen,
Nijmegen, Netherlands; 2 Sint Maartenskliniek, Nijmegen, Netherlands
Purpose: Over 50% of osteoarthritis (OA) patients show synovial
inﬂammation, even relatively early during the disease. However,
the mechanisms through which this synovial activation contributes
to the irreversible joint pathology that characterizes OA, are not
known. In the present study we used microarray analysis of
synovial tissue of early OA patients and of experimental OA, to
identify common pathways that determine cartilage damage in this
disease.
Methods: From a subpopulation of patients that entered the CHECK
Cohort study (Cohort Hip and Cohort Knee), synovial biopsies were
collected. CHECK is a prospective 10-year follow-up study that was
initiated by the Dutch Arthritis Association on participants with
early osteoarthritis-related complaints of hip and/or knee. Radio-
graphs are taken in a standardized manner and scored (Kell-
gren&Lawrence KL) at inclusion (n¼18). In addition, biopsies of 7
control synovia were collected. A longitudinal expression analysis
was performed on murine synovial tissue at day 7, day 21 and day
42 after induction of collagenase induced OA (CIOA). CIOA was
induced by intra-articular injection of collagenase, which causes
joint instability, and contra lateral knee joints served as controls.
Initial analysis of microarray data was performed using Partek
software and functional annotation clustering (FAC) and pathway
analysis was done using DAVID.
Results: Gene expression proﬁles of control synovia were compared
to CHECK synovia. Analysis using DAVID indicated enrichment of
several biological processes and signaling pathways, including
regulation of macrophage differentiation, innate immune responses,
cell migration, TGFb-, BMP- and wnt-signaling. This indicates clear
activation of the synovium in the CHECK patients compared to
controls. Next we compared synovial tissue of CHECK-patients with
radiological damage (KL1) with CHECK-patients without joint
damage (KL¼0). Among the top 30 genes that were strongest asso-
ciated with cartilage damage were MMP-1 (18-fold), MMP-3 (10-
fold), S100A8 (6-fold) and cartilage glycoprotein-39 (6-fold), all of
which have been associated with cartilage damage. Immunohisto-
chemical staining revealed that expression of MMP-1 and MMP-3
was highest in the synovial lining layer. FAC analysis showed that,
among others, response to wounding, chemotaxis, innate immune
response and metalloproteases were strongly and signiﬁcantly
enriched and thus associated with joint damage. Pathway analysis
demonstrated that in the synovium of patients with joint damage
the complement-activation pathway, TGFb- and BMP-signaling and
TLR-activation were signiﬁcantly upregulated. These results were
further underlined by analysis of synovium from experimental OA.
Among the genes that were strongly upregulated on all 3 time points
after induction were MMP-3 (6-fold), MMP-13 (16-fold), MMP-14 (6-
fold) and COMP (13-fold). Again, wound healing, innate immune
response and metalloproteases were signiﬁcantly enriched, as were
the complement pathway, the TLR-, TGFb, BMP and wnt-signaling
pathways. In a recent publication, complement was demonstrated to
be essential in experimental OA. We therefore determined whether
